SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-11-005053
Filing Date
2011-08-15
Accepted
2011-08-15 16:36:00
Documents
3
Period of Report
2011-08-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 NPS PHARMACEUTICALS, INC. 8-K a6829248.htm 8-K 22291
2 EXHIBIT 10.1 a6829248ex10_1.htm EX-10.1 23970
3 EXHIBIT 99.1 a6829248ex99_1.htm EX-99.1 5344
  Complete submission text file 0001157523-11-005053.txt   52740
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23272 | Film No.: 111036939
SIC: 2836 Biological Products, (No Diagnostic Substances)